로딩 중…
StockDiggingStockDigging

GemVax

082270· KOSDAQ
₩13,260-4.60%
2026-06-19

Price Chart

GemVax-80.89%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap587.01B KRW
Revenue87.41B KRW
Net Income1.65B KRW
Total Assets176.23B KRW
Net Assets57.23B KRW
Employees199
Value
P/E355.90x
P/B10.26x
P/S6.72x
EV/EBITDA67.28x
FCF Yield0.02%
Profitability
ROE2.88%
ROA0.94%
Op. Margin11.12%
Revenue Growth47.56%
Financial Health
Debt Ratio166.88%
Total Debt90.93B KRW
FCF111.3M KRW
Cash23.96B KRW
Current Ratio1.18x
Net Debt/EBITDA6.89x
Performance
1Y Return-80.89%
1M Return-22.18%
From 52W High-81.76%
1Y MDD-82.99%
Trading
Volume342,082 shares
Foreign Own.7.77%
Per Share
EPS-93 KRW
BPS1,837 KRW

Company Info

CEO 김기호, 이석준
Employees 199
Founded 1998
HQ 경기도 성남시, KR

GemVax, established in 1998 for the manufacturing and sale of Coating Resin and filters, was listed on the KOSDAQ market in 2005. In its environmental pollution control division, the company specializes in localizing Chemical Filters for semiconductor and display applications, as well as providing air pollution prevention equipment. The bio division conducts clinical trials for diseases such as Alzheimer's using GV1001, simultaneously focusing on expanding overseas demand and researching next-generation peptide drugs. GemVax is headquartered in Seongnam City, Gyeonggi-do.